Back to search
FDAFDA · Food and drugs·Recall number D-1252-2019

Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.

Published April 24, 2019 · Recall initiated: April 2, 2019

Summary

FDA records drug Class III recall D-1252-2019, published April 24, 2019 and initiated April 2, 2019. Recalling firm: Johnson Matthey Inc.; Status: Terminated; Reported quantity: 416.95 g glass container; Lot: Lot #: B1319-170101. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Johnson Matthey Inc.
Distributor
Product was distributed to one manufacturer in Morgantown, WV who may have manufactured the product into finished product and further distribute to the retail level Nationwide in the USA.
Lot
Lot #: B1319-170101
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742. recalled?

Yes. FDA published recall D-1252-2019 on April 24, 2019. Reported hazard: Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail